Literature DB >> 19597733

Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis.

Bozena Targońska-Stepniak1, Magdalena Dryglewska, Maria Majdan.   

Abstract

Adipose tissue is regarded as an active metabolic and endocrine organ producing adipokines. The purpose of the study was to evaluate adiponectin and leptin concentrations in rheumatoid arthritis (RA) patients (pts) in relation to disease duration and activity. The study group consisted of 80 RA pts. Serum adiponectin and leptin concentrations remained within normal ranges. Adiponectin concentration correlated positively both with the age and disease duration. Both adipokines levels correlated negatively with glomerular filtration rate. There were significant positive correlations between adipokines' concentrations and lipid profile components (between adiponectin and HDL-cholesterol, leptin and total cholesterol and LDL-cholesterol). In pts with long-standing RA, there was a negative correlation between adiponectin and numbers of tender, swollen joints and a positive relationship between leptin level and DAS28. The results confirm adipokines' involvement in the process of inflammation and atherosclerosis: protective and antiinflammatory adiponectin effect and proatherogenic and proinflammatory leptin function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597733     DOI: 10.1007/s00296-009-1053-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  41 in total

1.  No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis.

Authors:  P Härle; P Sarzi-Puttini; M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2006-07       Impact factor: 19.103

2.  Serum leptin levels in patients with rheumatoid arthritis.

Authors:  M Salazar-Páramo; M González-Ortiz; L González-López; A Sánchez-Ortiz; I C Valera-González; E Martínez-Abundis; B R Balcázar-Muñoz; A García-González; J I Gámez-Nava
Journal:  J Clin Rheumatol       Date:  2001-02       Impact factor: 3.517

3.  Serum leptin levels in rheumatoid arthritis and relationship with disease activity.

Authors:  Rezzan Gunaydin; Taciser Kaya; Aysenur Atay; Nese Olmez; Aysel Hur; Mehmet Koseoglu
Journal:  South Med J       Date:  2006-10       Impact factor: 0.954

Review 4.  Leptin, from fat to inflammation: old questions and new insights.

Authors:  Miguel Otero; Rocío Lago; Francisca Lago; Felipe F Casanueva; Carlos Dieguez; Juan Jesús Gómez-Reino; Oreste Gualillo
Journal:  FEBS Lett       Date:  2005-01-17       Impact factor: 4.124

Review 5.  The contribution of adipose tissue and adipokines to inflammation in joint diseases.

Authors:  Eric Toussirot; Gérald Streit; Daniel Wendling
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

6.  Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity.

Authors:  Bozena Targońska-Stepniak; Maria Majdan; Magdalena Dryglewska
Journal:  Rheumatol Int       Date:  2007-10-30       Impact factor: 2.631

7.  Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.

Authors:  S-W Lee; J-H Kim; M-C Park; Y-B Park; S-K Lee
Journal:  Scand J Rheumatol       Date:  2008 Jul-Aug       Impact factor: 3.641

8.  Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis.

Authors:  Joseph Walsmith; Leslie Abad; Joseph Kehayias; Ronenn Roubenoff
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

Review 9.  The role of leptin in innate and adaptive immune responses.

Authors:  Eiva Bernotiene; Gaby Palmer; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Role of resistin as a marker of inflammation in systemic lupus erythematosus.

Authors:  Katarina Almehed; Helena Forsblad d'Elia; Maria Bokarewa; Hans Carlsten
Journal:  Arthritis Res Ther       Date:  2008-01-30       Impact factor: 5.156

View more
  20 in total

1.  Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.

Authors:  Daniel H Solomon; Thorvardur Jon Love; Claire Canning; Sebastian Schneeweiss
Journal:  Ann Rheum Dis       Date:  2010-06-28       Impact factor: 19.103

2.  Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Patrick H Dessein; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Ahmed Solomon
Journal:  Rheumatol Int       Date:  2014-01-08       Impact factor: 2.631

Review 3.  What's new in our understanding of the role of adipokines in rheumatic diseases?

Authors:  Rodolfo Gómez; Javier Conde; Morena Scotece; Juan Jesus Gómez-Reino; Francisca Lago; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

Review 4.  Leptin in the interplay of inflammation, metabolism and immune system disorders.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Jesús Pino; Miguel Angel Gonzalez-Gay; Juan J Gómez-Reino; Antonio Mera; Francisca Lago; Rodolfo Gómez; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

Review 5.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

6.  Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis.

Authors:  José Antonio De Jesús Batún-Garrido; Marisol Salas-Magaña; Isela Esther Juárez-Rojop
Journal:  Clin Rheumatol       Date:  2017-11-03       Impact factor: 2.980

Review 7.  Atherosclerosis in rheumatoid arthritis: is it all about inflammation?

Authors:  Sarah Skeoch; Ian N Bruce
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

8.  Increased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers.

Authors:  Andreina Bruno; Marinella Alessi; Simona Soresi; Anna Bonanno; Loredana Riccobono; Angela Marina Montalbano; Giusy Daniela Albano; Mark Gjomarkaj; Mirella Profita
Journal:  J Inflamm Res       Date:  2011-05-20

Review 9.  Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.

Authors:  Fernanda Genre; Raquel López-Mejías; José A Miranda-Filloy; Begoña Ubilla; Beatriz Carnero-López; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Biomed Res Int       Date:  2014-03-18       Impact factor: 3.411

Review 10.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.